Alireza Atri
@TheDrAtri
Followers
271
Following
142
Media
1
Statuses
91
Brain Doc dedicated 2ending #Alzheimers Disease &related dementias 4future generations; imagine a world w/o brain degeneration& #dementia! Tweets r my own views
Joined August 2019
RT @PaolaBarbarino: ¡Únase a @TheDrAtri- uno de los científicos más ocupados del mundo en la búsqueda de un tratamiento para el Alzheimer….
0
2
0
RT @PaolaBarbarino: Please help @alzheimersja and many other organisations get proper #dementia and #alzheimers plans and strategies for th….
0
3
0
RT @PaolaBarbarino: Lecanemab - to be called Leqembi has received approval from the US Food and Drug Administrattin for those living with #….
0
8
0
RT @PaolaBarbarino: If you are prescribed hearing aids please wear them! Further evidence this month points to a correlation between correc….
0
3
0
RT @PaolaBarbarino: This is something I have wanted to do from the first month I started at @AlzDisInt. It is so important as so many count….
0
3
0
RT @PaolaBarbarino: Caution needed as usual, but the results just published on Lecanemab, a possible breaktrough therapy for the early stag….
nejm.org
The accumulation of soluble and insoluble aggregated amyloid-beta (Aβ) may initiate or potentiate pathologic processes in Alzheimer’s disease. Lecanemab, a humanized IgG1 monoclonal antibody that b...
0
7
0
RT @EricTopol: About 1 in 5 of us have an APOE4 gene variant, the #1 genetic risk factor for Alzheimer's disease. But the mechanism for bra….
0
193
0
Persons with #Parkinson disease were found to be at four times the risk of #dementia compared to sex and age matched persons w/o #Parkinsons using Swedish Registry data. PD is not just disease that impacts motor functions.
#Parkinsonsdisease is not only a movement disorder. Many patients experience non-motor symptoms, and it is often overlooked that individuals living with #Parkinsons are at greatly increased risk for #dementia. By how much? See our new paper.
0
1
3
RT @ApostolovaLiana: BEST NEWS EVER! I am so happy for our patients. At long last we have a positive trial.
eisai.com
Eisai's news release LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF...
0
21
0
RT @LarsRaket: My paper on statistical disease progression modeling in Alzheimer's disease has just been published in @FrontAIBigData. You….
0
5
0
RT @shanothiya: Looking forward to the @harvardmed #dementia research update conference in September 2022. #geriatrics @AmerGeriatrics htt….
0
2
0
RT @AartiShahAfrica: This was a stark reminder that we can reduce our own risks. This past week in the Global Regen CoLab, there have been….
0
1
0
RT @AartiShahAfrica: @TheDrAtri Human beings are members of a whole,.In creation of one essence and soul. If one member is afflicted with p….
0
1
0
RT @ApostolovaLiana: For fluid BM aficionados: DADM recently published an editorial and two papers discussing fluid BM variability by race….
0
5
0
RT @PaolaBarbarino: WHO launches today an important initiative to sensitise governments to #brainhealth. #dementia and #alzheimers are part….
0
15
0
RT @nfranzme: Important take away messages for amyloid lowering therapies in AD by @TheDrAtri #AAIC22
0
1
0
RT @LarsRaket: Are you interested in how one can estimate more interpretable treatment effects of disease modifying therapies in #Alzheimer….
0
5
0
RT @LarsRaket: How can one jointly estimate a time-consistent trajectory of multiple biomarkers' evolution over the #Alzheimers continuum?….
0
9
0